| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/02/2000 | EP0975648A1 Morphine derivatives |
| 02/02/2000 | EP0975640A1 Vinca alkaloid antimitotic halogenated derivatives |
| 02/02/2000 | EP0975639A1 Compounds |
| 02/02/2000 | EP0975637A2 Amidino-camptothecin derivatives |
| 02/02/2000 | EP0975636A1 Novel compounds |
| 02/02/2000 | EP0975633A1 5,6,7-trisubstituted-4-aminopyridol 2,3-d]pyrimidine compounds |
| 02/02/2000 | EP0975632A1 Alkaloid halide salts of swainsonine and methods of use |
| 02/02/2000 | EP0975631A1 5-aryl-3-(8-azabicyclo(3.2.2)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives as 5-ht4 receptor ligands |
| 02/02/2000 | EP0975629A1 Treatment or prophylaxis of prostatic cancer and benign prostatic hyperplasia with selective estrogen receptor modulators |
| 02/02/2000 | EP0975628A1 Prevention of breast cancer with selective estrogen receptor modulators |
| 02/02/2000 | EP0975627A1 5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2 adrenoceptor agonists |
| 02/02/2000 | EP0975625A1 SELECTIVE FACTOR Xa INHIBITORS |
| 02/02/2000 | EP0975624A1 Thermogenic composition and benzazepine thermogenics |
| 02/02/2000 | EP0975623A2 Indazole amide compounds as serotoninergic agents |
| 02/02/2000 | EP0975621A1 Cell differentiation inducing amide derivatives, their production and use |
| 02/02/2000 | EP0975618A1 A new process |
| 02/02/2000 | EP0975617A1 Inhibitors of cholesterol esterase |
| 02/02/2000 | EP0975614A1 A bicyclic aryl or a bicyclic heterocyclic ring containing compounds having a combined 5ht1a, 5ht1b and 5ht1d receptor antagonistic activity |
| 02/02/2000 | EP0975612A1 Protease inhibitors |
| 02/02/2000 | EP0975610A1 Tripeptide and tetrapeptide pharmaceutical compounds |
| 02/02/2000 | EP0975609A1 Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent |
| 02/02/2000 | EP0975608A2 Halo-alkoxycarbonyl prodrugs |
| 02/02/2000 | EP0975606A1 Crambescidin compounds |
| 02/02/2000 | EP0975605A1 Pyridazine and phthalazine derivatives, process of their preparation and their use as anticonvulsants |
| 02/02/2000 | EP0975603A1 Inhibitors of farnesyl protein transferase |
| 02/02/2000 | EP0975602A1 Imidazole and imidazoline derivatives and uses thereof |
| 02/02/2000 | EP0975600A1 Heterocyclic derivatives and their use as antithrombotic agents |
| 02/02/2000 | EP0975599A1 Subtituted isoquinolines as ultra short acting neuromuscular blockers |
| 02/02/2000 | EP0975598A1 Process and intermediates for the preparation of 4'-trifluoromethyl-biphenyl-2-carboxylic acid (1,2,3,4-tetrahydro-isoquinolin-6-yl)-amide |
| 02/02/2000 | EP0975596A1 Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors |
| 02/02/2000 | EP0975595A1 Analogs of cocaine |
| 02/02/2000 | EP0975593A1 Indole derivatives having combined 5ht1a, 5ht1b and 5ht1d receptor antagonist activity |
| 02/02/2000 | EP0975592A1 Benzyloxy prodigiosine compounds |
| 02/02/2000 | EP0975589A2 Dialkyl ureas as calcitonin mimetics |
| 02/02/2000 | EP0975588A1 Antipicornaviral compouds, compositions containing them, and methods for their use |
| 02/02/2000 | EP0975585A1 Process for preparing o-(3-amino-2-hydroxy-propyl)-hydroxymic acid halides |
| 02/02/2000 | EP0975581A1 Solid compositions suitable for oral administration comprising l-carnitine or alkanoyl-l-carnitine choline tartrate |
| 02/02/2000 | EP0975573A1 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity |
| 02/02/2000 | EP0975370A2 Composition and method for enhancing transport across biological membranes |
| 02/02/2000 | EP0975366A1 Cytoprotective agents comprising monoamine oxidase inhibitors |
| 02/02/2000 | EP0975365A1 Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis or growth of dms |
| 02/02/2000 | EP0975364A1 Allergen formulation |
| 02/02/2000 | EP0975361A1 Methods of modulating immune coagulation |
| 02/02/2000 | EP0975349A1 Serine proteinase inhibitory activity by hydrophobic tetracycline |
| 02/02/2000 | EP0975348A1 Stabilized tibolone compositions |
| 02/02/2000 | EP0975347A1 Synergistic combination of pde inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists |
| 02/02/2000 | EP0975346A1 Pharmaceutical, cosmetic and/or food composition with antioxidant properties |
| 02/02/2000 | EP0975345A1 (-)-mefloquine to block purinergic receptors and to treat movement or neurodegenerative disorders |
| 02/02/2000 | EP0975344A1 Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, motion sickness and vertigo |
| 02/02/2000 | EP0975343A1 Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor |
| 02/02/2000 | EP0975342A1 Pharmaceutical formulations comprising amoxocyllin and clavulanate |
| 02/02/2000 | EP0975341A1 Synergistic antitumor composition containing a naphthalensulphonic acid derivative |
| 02/02/2000 | EP0975340A2 Therapeutic inhibitor of vascular smooth muscle cells |
| 02/02/2000 | EP0975339A1 Pharmaceutical composition for the programmed release of dexfenfluramine |
| 02/02/2000 | EP0975338A2 2,2'-bi-1h-pyrrole derivatives useful in the treatment of leukemia brought on by htlv-i |
| 02/02/2000 | EP0975337A2 Fast release compressed tablet of flurbiprofen |
| 02/02/2000 | EP0975330A1 Pain reducing parenteral liposome formulation |
| 02/02/2000 | EP0975329A1 Lipid complexes and liposomes of highly insoluble platinum complexes |
| 02/02/2000 | EP0975327A1 Use of 5ht3 antagonists for promoting intestinal lavage |
| 02/02/2000 | EP0975325A1 Compositions comprising a combination of a free sphingoid base and a ceramide and uses thereof |
| 02/02/2000 | EP0975319A1 Skin care compositions containing an acid and a retinoid |
| 02/02/2000 | EP0975234A2 PROCESS FOR ENHANCING IMMUNE RESPONSE IN ANIMALS USING $g(b)-CAROTENE AS A DIETARY SUPPLEMENT |
| 02/02/2000 | EP0975223A1 In-situ generation of zinc pyrithione |
| 02/02/2000 | EP0975219A1 Fungicide active substance combinations |
| 02/02/2000 | EP0975218A1 Nucleophile substituted ecteinascidins and n-oxide ecteinascidins |
| 02/02/2000 | EP0975216A1 A method for treating papillomavirus infections |
| 02/02/2000 | EP0900078B1 Use of benzonaphthalene derivatives to make medicaments for treating diseases of the central nervous system |
| 02/02/2000 | EP0881891A4 Male contraceptive implant |
| 02/02/2000 | EP0863915B1 Acylated enol derivatives of alpha-ketoesters and alpha-ketoamides |
| 02/02/2000 | EP0850058A4 Facilitation of ampa receptor-mediated synaptic transmission in brain as a treatment for schizophrenia |
| 02/02/2000 | EP0820284B1 Biologically active ureido derivatives useful in the treatment of multiple sclerosis |
| 02/02/2000 | EP0804185B1 Arsenic medicaments for the treatment of chronic fatigue syndrome |
| 02/02/2000 | EP0789686B1 Retinoylamide based derivatives of sphingoid bases |
| 02/02/2000 | EP0767794B1 Phosphinic acid derivatives |
| 02/02/2000 | EP0730463B1 Use of lithium compounds in the treatment and prevention of alzheimer's disease |
| 02/02/2000 | EP0708627B1 Method and device for providing nicotine replacement therapy transdermally/transbuccally |
| 02/02/2000 | EP0674516B1 Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds |
| 02/02/2000 | EP0648126B1 Pharmaceutical preparations for inhibiting tumours associated with prostate adenocarcinoma, stomach cancer and breast cancer |
| 02/02/2000 | EP0592557B1 Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients |
| 02/02/2000 | CN1243544A Novel IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons |
| 02/02/2000 | CN1243543A Purification and/or concentration of DNA by cross-flow filtration, separation of endotoxins from nucleic acid preparation |
| 02/02/2000 | CN1243513A Quinoline and quinozoline compounds useful in therapy, particularly in the theatment of begnin prostatic hyperplasia |
| 02/02/2000 | CN1243512A New process |
| 02/02/2000 | CN1243510A Tricyclicbenzo [3] isoindole and benzo (h) isoquinoline |
| 02/02/2000 | CN1243507A Bis-sulfonomides hydroxamic acids as MMP inhibitors |
| 02/02/2000 | CN1243506A Novel modifications to 2-amino-4 (4-fluorobenzylamino)-1-ethoxycarbonyl-aminobenzene and processes for preparing said compound |
| 02/02/2000 | CN1243445A Photochemotherapeutic compositions |
| 02/02/2000 | CN1243441A Cervical maturing agent |
| 02/02/2000 | CN1243440A Dosage forms and method for ameliorating male erectile dysfunction |
| 02/02/2000 | CN1243439A Use of prumipexole in the treating of restless legs syndrome |
| 02/02/2000 | CN1243438A Pharmaceutical composition of fenofibrate with high biological utilizing rate |
| 02/02/2000 | CN1243437A Use of dichlorobenzyl alchol for preparing a preparation for topical treatment of inflammation and preparation containing dichlorobenzyl alchol |
| 02/02/2000 | CN1243436A New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof |
| 02/02/2000 | CN1243435A New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising formoterol |
| 02/02/2000 | CN1243434A New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising budesonide |
| 02/02/2000 | CN1243431A 皮肤制剂 Skin Product |
| 02/02/2000 | CN1243159A Calsium-enriched wine and preparation method thereof |
| 02/02/2000 | CN1243129A Steroid oside compound for treating cancer and preparation method thereof |
| 02/02/2000 | CN1243128A Semisynthesizing method for 20(S)-ginsenoside Rg3, and use in medicine |
| 02/02/2000 | CN1243125A Polyglutaminic acid or sodium polyglutamate taxinine A ester compound and use thereof |